Literature DB >> 28899074

Thyroid-Specific T Cells in Patients With Differentiated Thyroid Cancer: Implications for Immune-Based Therapies?

Jena D French1, Bryan R Haugen1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28899074      PMCID： PMC5505208          DOI： 10.1210/jc.2017-00058

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  4 in total

1.  Tumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary thyroid cancer.

Authors:  Jena D French; Zachary J Weber; Deborah L Fretwell; Sherif Said; Joshua P Klopper; Bryan R Haugen
Journal:  J Clin Endocrinol Metab       Date:  2010-03-05       Impact factor: 5.958

Review 2.  Leveraging the immune system to treat advanced thyroid cancers.

Authors:  Jena D French; Keith Bible; Christine Spitzweg; Bryan R Haugen; Mabel Ryder
Journal:  Lancet Diabetes Endocrinol       Date:  2016-10-20       Impact factor: 32.069

3.  Epitope-Specific Antitumor Immunity Suppresses Tumor Spread in Papillary Thyroid Cancer.

Authors:  Margret Ehlers; Anne Kuebart; Hubertus Hautzel; Juergen Enczmann; Anna-Carinna Reis; Matthias Haase; Stephanie Allelein; Till Dringenberg; Christine Schmid; Matthias Schott
Journal:  J Clin Endocrinol Metab       Date:  2017-07-01       Impact factor: 5.958

4.  Tumor-Infiltrating T Cells and the PD-1 Checkpoint Pathway in Advanced Differentiated and Anaplastic Thyroid Cancer.

Authors:  Jill J Bastman; Hilary S Serracino; Yuwen Zhu; Michelle R Koenig; Valerica Mateescu; Sharon B Sams; Kurtis D Davies; Christopher D Raeburn; Robert C McIntyre; Bryan R Haugen; Jena D French
Journal:  J Clin Endocrinol Metab       Date:  2016-04-05       Impact factor: 5.958
  4 in total
  3 in total

Review 1.  Recent advances in understanding immune phenotypes of thyroid carcinomas: prognostication and emerging therapies.

Authors:  Federica Liotti; Nella Prevete; Giancarlo Vecchio; Rosa Marina Melillo
Journal:  F1000Res       Date:  2019-02-28

2.  Nevirapine inhibits migration and invasion in dedifferentiated thyroid cancer cells.

Authors:  Hongxia Shang; Junyu Zhao; Jinming Yao; Huanjun Wang; Shengnan Wang; Jianjun Dong; Lin Liao
Journal:  Thorac Cancer       Date:  2019-10-21       Impact factor: 3.500

3.  Identification of Transcriptional Pattern Related to Immune Cell Infiltration With Gene Co-Expression Network in Papillary Thyroid Cancer.

Authors:  Meiye Li; Jimei Zhang; Zongjing Zhang; Ying Qian; Wei Qu; Zhaoshun Jiang; Baochang Zhao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-04       Impact factor: 5.555
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.